Preparation, characterization, and antibacterial competence of silymarin and its nano-formulation
Source abstract
Abstract
Nowadays, antibiotic resistance is a serious problem, especially in countries that have unregulated use of antibiotics. We aimed to prepare and characterize Sily-Nano from silymarin to present its antimicrobial activities in comparison to silymarin and gentamycin and provide natural antibacterial from natural sources. Silymarin NPs (Sily-Nano) were prepared using a high-pressure homogenization and characterized using X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), ultraviolet-visible (UV-visible) spectrum, and scanning electron microscopy (SEM). The antibacterial monitoring of Sily-Nano and silymarin was compared against Escherichia coli UN75 (E.coli-UN75), Enterobacter aerogenes SL3 (E.aerogenes-SL3), Staphylococcus aureus-PS41 (S.aureus-PS41), and Klebsiella pneumoniae-BD29 (K.pneumoniae-BD29). Sily-Nano was effectively prepared and confirmed using FTIR. SEM, with even distribution, and significant bacterial zone inhibition, compared with silymarin. In conclusion, Sily-Nano preparation is an efficient agent, and effective against certain clinical antibiotic-resistant bacterial strains. Sily-Nano has a novel significant inhibitory effect against the antibiotic-resistant strain of K. pneumonia-BD29, Ent. Aerogenes-SL3 and E. coli UN75 when compared with silymarin and the common antibiotic gentamycin. Therefore, sily-Nano is potentially used as an antibacterial and natural sanitizer agent.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Silymarin and Mushroom Poisoning · Synthesis and bioactivity of alkaloids · Berberine and alkaloids research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, College of Science, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
Basic and Applied Scientific Research Center, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
Department of Biology, College of Science, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
Department of Nano-Medicine Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
References (32)
Show source-provided references
1. 10.1016/j.colsurfb.2017.03.00410.1016/j.colsurfb.2017.03.004 ↗
2. 10.3390/molecules2411215510.3390/molecules24112155 ↗
3. 10.1596/978-0-1952-1107-810.1596/978-0-1952-1107-8 ↗
4. 10.1248/cpb.57.54510.1248/cpb.57.545 ↗
5. Ghosh A · J Pharm Sci Tech · 2010 · 2 · 348
6. 10.1016/j.biopha.2021.11202410.1016/j.biopha.2021.112024 ↗
7. 10.1111/j.1745-7254.2007.00487.x10.1111/j.1745-7254.2007.00487.x ↗
8. 10.1177/153473540730194210.1177/1534735407301942 ↗
9. 10.1002/hep.2617910.1002/hep.26179 ↗
10. 10.1007/s10096-012-1789-110.1007/s10096-012-1789-1 ↗
11. 10.1053/j.gastro.2007.02.03810.1053/j.gastro.2007.02.038 ↗
12. 10.1128/aem.60.5.1646-1651.199410.1128/aem.60.5.1646-1651.1994 ↗
13. NCCLS-National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 6th ed. Villanova, PA: NCCLS Approved Standard M7-A5; 2005. p. 20.
14. 10.1128/AAC.46.8.2720-2722.200210.1128/AAC.46.8.2720-2722.2002 ↗
15. 10.1186/s12866-021-02394-w10.1186/s12866-021-02394-w ↗
16. 10.1186/1472-6882-11-610.1186/1472-6882-11-6 ↗
17. 10.1186/1472-6882-11-5210.1186/1472-6882-11-52 ↗
18. 10.1002/(SICI)1099-1565(200005/06)11:3<137::AID-PCA514>3.0.CO;2-I10.1002/(SICI)1099-1565(200005/06)11:3<137::AID-PCA514>3.0.CO;2-I ↗
19. 10.1007/s12010-019-03177-w10.1007/s12010-019-03177-w ↗
20. 10.1053/jhep.2000.977010.1053/jhep.2000.9770 ↗
21. 10.5507/bp.2005.00210.5507/bp.2005.002 ↗
22. Babatunde OA · World News Nat Sci · 2021 · 37 · 75
23. 10.3390/pharmaceutics1305066010.3390/pharmaceutics13050660 ↗
24. 10.1080/10408398.2020.172206010.1080/10408398.2020.1722060 ↗
25. 10.1007/s00203-010-0617-110.1007/s00203-010-0617-1 ↗
26. 10.1016/j.bmc.2008.09.06410.1016/j.bmc.2008.09.064 ↗
27. 10.1016/j.bmc.2012.05.05010.1016/j.bmc.2012.05.050 ↗
28. 10.3390/nano911162910.3390/nano9111629 ↗
29. Arif T · 2011 · 283
30. 10.1016/j.msec.2019.02.01010.1016/j.msec.2019.02.010 ↗
31. 10.1186/s13756-019-0559-610.1186/s13756-019-0559-6 ↗
32. Oliveira DR · Biomed Res Int · 2015 · 2015 · 292797